EMEA-001487-PIP01-13 - paediatric investigation plan

Gevokizumab

Key facts

• Active Substance:
  Gevokizumab
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0148/2014
• PIP number:
  EMEA-001487-PIP01-13
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of chronic non-infectious uveitis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  13/06/2014

Decision

P/0148/2014: EMA decision of 13 June 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for gevokizumab (EMEA-001487-PIP01-13)

AdoptedReference Number: EMA/268731/2014